# Pandemic-Induced Disruption and the Adaptive Resilience of the Medical Supply Chain: A Case Study of Saudi Arabia

**Authors:** Omar Darkhabani, Abdalla Ahmed

PMC · DOI: 10.7759/cureus.104419 · Cureus · 2026-02-27

## TL;DR

This paper examines how Saudi Arabia's medical supply chain adapted during the pandemic by combining government and private sector efforts to overcome shortages.

## Contribution

The study introduces a hybrid resilience model combining centralized and decentralized strategies for medical supply chain management.

## Key findings

- Saudi Arabia transitioned from scarcity to surplus by leveraging centralized procurement and regulatory agility.
- Private sector digital logistics investments improved distribution efficiency during the crisis.
- The success highlights the need for localized manufacturing and advanced technologies in future supply chains.

## Abstract

The COVID-19 pandemic exposed profound vulnerabilities in global medical supply chains, largely driven by a reliance on Just-In-Time (JIT) efficiency and geographically concentrated manufacturing. While many Western economies faced sustained shortages and distribution chaos, the Kingdom of Saudi Arabia (KSA) achieved a rapid transition from initial scarcity to a surplus of essential supplies. This report analyzes the Saudi Arabian experience as a successful hybrid resilience model that synthesized centralized government authority with decentralized private sector agility. Centrally, the National Unified Procurement Company (NUPCO) utilized unified purchasing power to secure international deals, while the Saudi Food and Drug Authority (SFDA) provided regulatory agility by fast-tracking imports and registrations. Complementing this, major private distributors like Al Nahdi Medical Company reported digital logistics
investments enabling distribution efficiency. The study concludes that Saudi Arabia's success stemmed from the ability to rapidly pivot from cost-efficiency to security and speed operations. For future preparedness, the report advocates for a paradigm shift that prioritizes localization of manufacturing, supply chain diversification, and the integration of advanced technologies like AI and blockchain to ensure long-term national health security.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096)

## Full-text entities

- **Diseases:** COVID-19 (MESH:D000086382)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13033813/full.md

## References

19 references — full list in the complete paper: https://tomesphere.com/paper/PMC13033813/full.md

---
Source: https://tomesphere.com/paper/PMC13033813